Quantcast
Aspirin May Reduce The Risk Of Blood Clots Reoccurring

Aspirin May Reduce The Risk Of Blood Clots Reoccurring

American Heart Association Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins, according to new research in the American Heart Association journal...

Latest Deep vein thrombosis Stories

2014-08-25 23:02:39

The Firm is evaluating testosterone lawsuits on behalf of men who suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism, and other cardiovascular injuries, allegedly due to their use of prescription low testosterone therapies. New York, New York (PRWEB) August 25, 2014 Testosterone treatment lawsuits (http://www.injurybeacon.com/testosterone-androgel/) continue to move forward in a multidistrict litigation now underway in U.S. District Court, Northern District of...

2014-08-20 23:07:40

Randy Fenninger to Lead Organization With Strategic Focus Aimed at Increasing Recognition of Life-Threatening Blood Clots and Their Impact on Public Health Rockville, MD (PRWEB) August 20, 2014 The National Blood Clot Alliance (NBCA), a nonprofit advocacy organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots, announces the appointment of Randy Fenninger, JD, as its new Chief Executive Officer (CEO). Fenninger, who...

2014-08-17 23:02:07

As Merck Moves Forward to Resolve 3,800 Pending NuvaRing Lawsuits in the U.S., Health Canada Issues Safety Alert for the Contraceptive NuvaRing Citing It May Be Harmful for Some Women Columbus, OH (PRWEB) August 17, 2014 As Merck looks to settle thousands of NuvaRing lawsuits alleging deep vein thrombosis and pulmonary embolisms in the U.S. under MDL 1964, Wright & Schulte LLC reports that Health Canada recently ordered new user restrictions for the use of the contraceptive device...

2014-08-06 23:11:18

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) August 06, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A recent report shows the maker of the drugs has settled approximately 8,900 cases alleging they caused side effects*. DrugNews is a free online resource...

2014-08-04 20:22:26

Follow these five quick tips from The California Institute of Deep Venous Thrombosis to avoid the pain and potentially life-threatening side effects of DVT LOS ANGELES, Aug. 4, 2014 /PRNewswire/ -- For most people, a well-paying white-collar job definitely beats the kind of hard physical labor that can often lead to a variety of health problems as we get older - and we all love our modern conveniences. However, a sedentary lifestyle can definitely lead to its share of health issues, including...

2014-07-30 12:30:01

Growth Will Be Driven Primarily By Adoption of Devices to Treat Stroke and Venous Thromboembolism, According to Findings from Decision Resources Group BURLINGTON, Mass., July 30, 2014 /PRNewswire/ -- Decision Resources Group finds that the United States clot management device market will expand through 2022, particularly in the later years. This will be primarily as a result of increasing uptake of neurovascular embolectomy devices, designed for treating stroke patients, as well as...

2014-07-23 23:13:00

The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) July 23, 2014 The birth control resource center at DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of new information on the site. A federal panel recently released updated records showing more than 8,500 cases still pending alleging side effects from the drugs*. DrugNews is a free online...

2014-07-23 16:26:55

British Medical Journal publishes biased article regarding PRADAXA RIDGEFIELD, Conn., July 23, 2014 /PRNewswire/ -- Boehringer Ingelheim (BI) wants to set the record straight following misleading statements that the British Medical Journal (BMJ) published today regarding Pradaxa® (dabigatran etexilate mesylate). We are concerned that this publication may alarm patients and prompt them to stop taking PRADAXA, thereby increasing their risk of stroke. To be clear, many of the allegations made...

2014-07-17 23:01:02

The Firm is actively investigating potential claims on behalf of patients who allegedly suffered Xarelto internal bleeding, strokes, pulmonary embolism and/or deep vein thrombosis following use of the blood thinner. New York, NY (PRWEB) July 17, 2014 Bernstein Liebhard LLP has launched a new website for individuals who may be eligible to file a Xarelto lawsuit (http://www.xareltolawsuitcenter.com/) alleging injuries caused by the new-generation blood thinner, the Firm reports. The site...

2014-07-15 12:28:34

CHICAGO, July 15, 2014 /PRNewswire/ -- At the encouragement of the patient safety community, the Physician-Patient Alliance for Health & Safety (PPAHS) has introduced the PPAHS Patient Safety Podcast, an ongoing series of online discussions that will explore important patient safety issues at health care facilities across the U.S. Focusing on opioid safety (pain management), venous thromboembolism (blood clots), and alarm management (noise fatigue), the PPAHS Patient Safety...


Word of the Day
bodacious
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'
Related